Both in Pharmaceuticals
Supernus vs Kailera Therapeutics
Over the past year SUPN returned −32.3% and KLRA returned −8.2%; their daily moves had a correlation of 0.16.
SUPN −32.3% KLRA −8.2%Growth of $1, one year, split-adjusted
| Metric | SUPN | KLRA |
|---|---|---|
| Price | $28.21 | $12.80 |
| Market cap | $1.64B | $1.66B |
| Today | +0.21% | +1.75% |
| 1 month | −34.1% | +18.2% |
| 6 months | −45.2% | — |
| Year to date | −43.2% | — |
| 1 year | — | — |
| Revenue growth (YoY) | +18.0% | — |
| Gross margin | 88.1% | — |
| Net margin | 9.2% | — |
| P/E (TTM) | — | — |
| Price / sales | 1.9× | — |
| Net cash | $359.5M | $916.7M |
| Dividend yield | 28.82% | — |
| Volatility (60d) | 86.1% | — |
| Short % of float | 7.3% | 9.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).